These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23975313)

  • 1. Incidence and consequence of close margins in patients with ductal carcinoma-in situ treated with mastectomy: is further therapy warranted?
    Fitzsullivan E; Lari SA; Smith B; Caudle AS; Krishnamurthy S; Lucci A; Mittendorf EA; Babiera GV; Black DM; Wagner JL; Bedrosian I; Woodward W; Gainer SM; Hwang R; Meric-Bernstam F; Hunt KK; Kuerer HM
    Ann Surg Oncol; 2013 Dec; 20(13):4103-12. PubMed ID: 23975313
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of Age on Locoregional and Distant Recurrence After Mastectomy for Ductal Carcinoma In Situ With or Without Microinvasion.
    Mamtani A; Nakhlis F; Downs-Canner S; Zabor EC; Morrow M; King TA; Van Zee KJ
    Ann Surg Oncol; 2019 Dec; 26(13):4264-4271. PubMed ID: 31440931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Risk of locoregional recurrence in patients with false-negative frozen section or close margins of retroareolar specimen in nipple-sparing mastectomy.
    Kneubil MC; Lohsiriwat V; Curigliano G; Brollo J; Botteri E; Rotmensz N; Martella S; Mastropasqua MG; Iera M; Coelho MB; Intra M; Orecchia R; Rey P; Rietjens M; Petit JY
    Ann Surg Oncol; 2012 Dec; 19(13):4117-23. PubMed ID: 22820937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of margin status on local recurrence after mastectomy for ductal carcinoma in situ.
    Childs SK; Chen YH; Duggan MM; Golshan M; Pochebit S; Punglia RS; Wong JS; Bellon JR
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(4):948-52. PubMed ID: 22975615
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mastectomy margins for ductal carcinoma-in-situ (DCIS): 18 Years of follow-up.
    ElSherif A; Freyvogel Ramirez M; Moore EC; Dietz JR; Tu C; Valente SA
    Am J Surg; 2023 Nov; 226(5):646-651. PubMed ID: 37481406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of local recurrence after mastectomy for pure ductal carcinoma
    Kim D; Ki Y; Kim W; Park D; Joo J; Jeon H; Nam J
    J Cancer Res Ther; 2020; 16(6):1197-1202. PubMed ID: 33342773
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the Number or Proximity of Margins Less than 2 mm Associated with an Increased Mastectomy Rate in Patients Attempting Breast Conservation Therapy for Ductal Carcinoma In Situ?
    Elmore LR; Bayley EM; Clark BZ; McAuliffe PF; Cowher MS
    Ann Surg Oncol; 2024 Oct; 31(11):7609-7618. PubMed ID: 39085550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Local Recurrence After Simple and Skin-Sparing Mastectomy Performed in Patients with Ductal Carcinoma In Situ.
    Timbrell S; Al-Himdani S; Shaw O; Tan K; Morris J; Bundred N
    Ann Surg Oncol; 2017 Apr; 24(4):1071-1076. PubMed ID: 27837296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microcalcifications in 1657 Patients with Pure Ductal Carcinoma in Situ of the Breast: Correlation with Clinical, Histopathologic, Biologic Features, and Local Recurrence.
    Rauch GM; Hobbs BP; Kuerer HM; Scoggins ME; Benveniste AP; Park YM; Caudle AS; Fox PS; Smith BD; Adrada BE; Krishnamurthy S; Yang WT
    Ann Surg Oncol; 2016 Feb; 23(2):482-9. PubMed ID: 26416712
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of surgical margins with local recurrence in patients undergoing breast-conserving surgery after neoadjuvant chemotherapy.
    Lin J; Lin KJ; Wang YF; Huang LH; Chen SL; Chen DR
    BMC Cancer; 2020 May; 20(1):451. PubMed ID: 32434493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes in patients treated with mastectomy for ductal carcinoma in situ.
    Owen D; Tyldesley S; Alexander C; Speers C; Truong P; Nichol A; Wai ES
    Int J Radiat Oncol Biol Phys; 2013 Mar; 85(3):e129-34. PubMed ID: 23195778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrence Outcomes After Nipple-Sparing Mastectomy and Immediate Breast Reconstruction in Patients with Pure Ductal Carcinoma In Situ.
    Wu ZY; Kim HJ; Lee J; Chung IY; Kim JS; Lee SB; Son BH; Eom JS; Kim SB; Gong GY; Kim HH; Ahn SH; Ko B
    Ann Surg Oncol; 2020 May; 27(5):1627-1635. PubMed ID: 31912259
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Margin Proximity Correlates with Local Recurrence After Mastectomy for Patients Not Receiving Adjuvant Radiotherapy.
    Glorioso JM; Gonzalez Juarrero AB; Rodysill BR; Harmsen WS; Habermann EB; Carter JM; Mutter RW; Degnim AC; Jakub JW
    Ann Surg Oncol; 2017 Oct; 24(11):3148-3156. PubMed ID: 28681156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreasing Recurrence Rates for Ductal Carcinoma In Situ: Analysis of 2996 Women Treated with Breast-Conserving Surgery Over 30 Years.
    Subhedar P; Olcese C; Patil S; Morrow M; Van Zee KJ
    Ann Surg Oncol; 2015 Oct; 22(10):3273-81. PubMed ID: 26215193
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The safety of multiple re-excisions after lumpectomy for breast cancer.
    Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
    Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Defining negative margins in DCIS patients treated with breast conservation therapy: The University of Chicago experience.
    Sahoo S; Recant WM; Jaskowiak N; Tong L; Heimann R
    Breast J; 2005; 11(4):242-7. PubMed ID: 15982389
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Are there patients with T1 to T2, lymph node-negative breast cancer who are "high-risk" for locoregional disease recurrence?
    Mamtani A; Patil S; Stempel MM; Morrow M
    Cancer; 2017 Jul; 123(14):2626-2633. PubMed ID: 28334423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological Safety of Skin-Sparing Mastectomy and Immediate Breast Reconstruction in Extensive Ductal Carcinoma In Situ.
    Tamminen A; Meretoja T; Koskivuo I
    J Surg Res; 2022 Nov; 279():25-32. PubMed ID: 35717793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical outcomes and prognosis of HER2+ invasive breast cancer patients with a DCIS component treated with breast-conserving surgery after neoadjuvant systemic therapy.
    Ploumen RAW; Claassens EL; Kooreman LFS; Keymeulen KBMI; van Kats MACE; van Kuijk SMJ; Siesling S; van Nijnatten TJA; Smidt ML
    Eur J Surg Oncol; 2024 Sep; 50(9):108465. PubMed ID: 38870869
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of ipsilateral breast tumor recurrence after breast-conserving surgery between ductal carcinoma in situ and invasive breast cancer.
    Choi YJ; Shin YD; Song YJ
    World J Surg Oncol; 2016 Apr; 14():126. PubMed ID: 27122132
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.